cervical cancer

The new test covers eight high-risk HPV genotypes, including 52 and 58 — now detectable at the point-of-care

Besides the high incidence of cervical cancer owing to its late diagnosis and with consequent poor survival, 25 per cent of global…

Ahead of the vaccination drive, an awareness campaign was conducted across 50+ schools, engaging over 1000 teachers, reaching more…

This test detects 14 high-risk HPV types in a single tube and is a clinically validated, FDA-approved, and WHO-prequalified…

Abhinav Bhatia, Trade Commissioner, South Asia, Trade and Investment Queensland (TIQ) explains how fostering international…

At least 144 countries have introduced the HPV vaccine, over 60 countries now include HPV testing in their cervical screening…

The initiative aims to reduce cervical cancer incidence through vaccination, screening, and preventive care

The test, also known by the brand name, CERViSure, is a quick, accurate, and non-invasive method to detect cervical cancer

The research study developed the protein Syntaxin 3 that can predict the patient’s response to radiation and chemotherapy before…

Navigating women's health complexities demands a multifaceted approach to addressing rising cancer rates